amisulpride


Also found in: Wikipedia.

amisulpride

An atypical antipsychotic, which has been used for treatment-resistant schizophrenia and manic episodes in major depression.

Adverse effect
Amenorrhoea, galactorrhoea in women, nausea, weight gain, insomnia, akathisia, sexual dysfunction, torsades de pointes.

amisulpride

A drug used in the treatment of SCHIZOPHRENIA. A brand name is Solian.
References in periodicals archive ?
dagger]) Twelve patients were receiving olanzapine, 8 on quetiapine, 4 on risperidone, 2 on chlorpromazine, and 1 each on amisulpride, aripiprazole, and trifluoperazine.
3] Many antipsychotics (both typical and atypical) like chlorpromazine, fluphenazine, haloperidol, trifluoperazine, amisulpride, olanzapine and risperidone have been implicated.
Her medications were aripiprazole 5 mg daily, irbesartan 150 mg daily, amisulpride 150 mg daily, imipramine 50 mg nocte, lercanidipine 10 mg daily, and sertraline 300 mg daily.
A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.
Within a week, her restlessness ameliorated, but her psychotic symptoms persisted hence tablet Amisulpride 50 mg/day was started, which was increased to 100 mg/day.
A literature review identified Amisulpride, Flupenthixol, Haloperidol, Levopromazine, Sulpiride, Thioridazine, Zuclopenthixol and second generation antipsychotics at higher doses (Aripiprazole, Olanzapine, Risperidone) as high risk of inducing Parkinson symptoms.
Finally, we found out that she had been taking amisulpride at 800 mg/day for the last eight months.
In the psychiatric unit, the patient was medicated with antipsychotics in therapeutic doses (olanzapine 15 mg/day in the first hospitalization and amisulpride 400 mg/day in the others four admissions) and a benzodiazepine (lorazepam 2,5 mg three times a day) for control of anxiety and insomnia.
The individual medications of atypical antipsychotics comprised amisulpride, clozapine, olanzapine, quetiapine, risperidone, and zotepine.
11) Studies of adjunctive atypical antipsychotics for dysthymic disorder are scarce; a Cochrane review identified controlled data only with amisulpride (not approved for use in the United States), which yielded a modest therapeutic effect.
It is indicated that amisulpride might cause secondary pseudomyopia and supplementation of anticholinergic agent might contribute to this side effect.